IndexValue Assertion: s2md_BV811-2
| Code | s2md_BV811-2 |
|---|---|
| Id | s2md_BV811-2 |
| Severity | ERROR |
| Aspect Model | dimensional |
| Implicit Filtering | true |
| Test | not(empty($a)) and not(empty($b)) and not(empty($c)) and not(empty($d)) and not(empty($e)) and not(empty($f)) and not(empty($g)) and not(empty($h)) and not(empty($i)) and not(empty($j)) and not(empty($k)) and not(empty($l)) and not(empty($m)) |
Unsatisfied Message(s)
| Lang | Role/Text |
|---|---|
| en | http://www.xbrl.org/2010/role/message |
| BV811-2: not(empty({{S.08.01.01.02,c0330}})) and not(empty({{S.08.01.01.01,c0060}})) and not(empty({{S.08.01.01.01,c0080}})) and not(empty({{S.08.01.01.01,c0110}})) and not(empty({{S.08.01.01.01,c0130}})) and not(empty({{S.08.01.01.01,c0220}})) and not(empty({{S.08.01.01.01,c0240}})) and not(empty({{S.08.01.01.01,c0250}})) and not(empty({{S.08.01.01.02,c0260}})) and not(empty({{S.08.01.01.02,c0360}})) and not(empty({{S.08.01.01.02,c0370}})) and not(empty({{S.08.01.01.02,c0400}})) and not(empty({{S.08.01.01.02,c0430}})) where matches({{S.08.01.01.02,c0380}},"^((XL)|(XT))..$") | |
| en | http://www.xbrl.org/2010/role/terseMessage |
| BV811-2: not(empty({{S.08.01.01.02,c0330}})) and not(empty({{S.08.01.01.01,c0060}})) and not(empty({{S.08.01.01.01,c0080}})) and not(empty({{S.08.01.01.01,c0110}})) and not(empty({{S.08.01.01.01,c0130}})) and not(empty({{S.08.01.01.01,c0220}})) and not(empty({{S.08.01.01.01,c0240}})) and not(empty({{S.08.01.01.01,c0250}})) and not(empty({{S.08.01.01.02,c0260}})) and not(empty({{S.08.01.01.02,c0360}})) and not(empty({{S.08.01.01.02,c0370}})) and not(empty({{S.08.01.01.02,c0400}})) and not(empty({{S.08.01.01.02,c0430}})) where matches({{S.08.01.01.02,c0380}},"^((XL)|(XT))..$") | |
Label(s)
| Lang | Role/Text |
|---|---|
| en | http://www.xbrl.org/2008/role/label |
| BV811: Items "Counterparty group" (for OTC derivatives), "Portfolio", "Derivatives held in index linked and unit linked contracts", "Use of derivative", "Notional amount of the derivative", "Initial date", "Solvency II value", "Valuation method", "Counterparty Name", "Contract name", "Currency", "Unwind trigger of contract" and "Maturity date" should be reported -->Template 1: S.08.01; Filter: {c0380} like 'XL##' or {c0380} like 'XT##' ; Expression: {c0330}<>empty and {c0060}<>empty and {c0080}<>empty and {c0110}<>empty and {c0130}<>empty and {c0220}<>empty and {c0240}<>empty and {c0250}<>empty and {c0260}<>empty and {c0360}<>empty and {c0370}<>empty and {c0400}<>empty and {c0430}<>empty | |
| en | http://www.xbrl.org/2008/role/verboseLabel |
| BV811: Items "Counterparty group" (for OTC derivatives), "Portfolio", "Derivatives held in index linked and unit linked contracts", "Use of derivative", "Notional amount of the derivative", "Initial date", "Solvency II value", "Valuation method", "Counterparty Name", "Contract name", "Currency", "Unwind trigger of contract" and "Maturity date" should be reported -->Template 1: S.08.01; Filter: {c0380} like 'XL##' or {c0380} like 'XT##' ; Expression: {c0330}<>empty and {c0060}<>empty and {c0080}<>empty and {c0110}<>empty and {c0130}<>empty and {c0220}<>empty and {c0240}<>empty and {c0250}<>empty and {c0260}<>empty and {c0360}<>empty and {c0370}<>empty and {c0400}<>empty and {c0430}<>empty | |